u/two_mil_or_one

Which country? Half the answers in this thread only apply in France.

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

You have restated the marketing copy. What is the actual substance here.

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

Sceptical. If this were true we would see it reflected in the data and we do not.

Cosigning. The GIP contribution is real and the side effects are not simply scaled versions.

integration decision on a shoulder changes your number by half a point on its own

nope, the equivalence to semaglutide is not known, comparing 15mg tirz to 2.4mg sema is guessing

my fasting insulin moved before the scale did and i nearly missed it

the thymosin literature is thin on humans

integration decision on a shoulder changes your number by half a point on its own

phase 2 numbers are not maintenance numbers, cite the trial

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

related substances are where the story lives, not the main peak

What was the column and what gradient?

Yeah, the chromatogram profile matters more than the headline number.